Friday, May 26, 2017

Harvey Nash Goes Smash

Harvey Nash Group (HVN) is a recruitment business. The company is diversified (no customer concentration risk) and operates in a number of geographies (e.g. UK, Europe, US). It trades for 56 million pounds, and I expect them to earn (based on their history) about 7 million per year. Since they have a net cash position of 5 million, this gives them an adjusted P/E of just over 7.

Thursday, May 4, 2017

Canam Goes Private

It feels like just last month that I was discussing Canam Group (CAM) as a new potential value investment - because it was. Thanks to extraordinarily lucky timing, I no longer own any shares, as last week the company's management (in concert with private equity) decided to take the company private.

Monday, May 1, 2017

Destiny of the Republic

Relative to what I'd like to know, I know very little about American history. But I plan to spend the rest of my lifetime fixing that! Fantastic books like Destiny of the Republic: A Tale of Madness, Medicine and the Murder of a President really help.

Friday, April 28, 2017

Stagecoach

Stagecoach owns and operates buses and trains in the UK, and to a lesser extent in Europe and America.

Tuesday, April 11, 2017

Dreamland

We spend a third of our lives sleeping, and yet we know so little about what goes on when we're under. I'm aware of countless studies that have demonstrated how important sleep is, and still I don't feel like I know enough to be getting the most out of it. It's with that in mind that I read Dreamland: Adventures in the Strange Science of Sleep.

Monday, April 10, 2017

Canam Group

Canam Group (CAM) is a previous holding of mine that has gotten very cheap again. I have written extensively about this stock in the past here.

Friday, April 7, 2017

Karsan Value Funds: 2017 Q1 Results

Karsan Value Funds (KVF) is a value-oriented fund, as described here. Due to securities regulations, the fund is not open to the public at this time. Should that change in the future, there will be an announcement on this site.

Follow by Email